Category: Healthcare and Life Sciences

Key Highlights Francisco Partners, a leading global investment firm, has agreed to sell QGenda, a pioneer in healthcare workforce management solutions, to Hearst Health. QGenda's ProviderCloud...

Firefly Neuroscience's Merger and Listing on Nasdaq: A Milestone for AI-Driven Brain Health Solutions Key Highlights Firefly Neuroscience has completed its merger with WaveDancer, Inc. and begun...

Baxter's Divestment of Kidney Care Business to Carlyle Group: A Strategic Realignment In a strategic move to focus on its core competencies, Baxter International Inc., a leading global healthcare...

Neuronetics and Greenbrook TMS Merger - Introduction In a groundbreaking move for the mental health industry, Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) have announced...

Revance Therapeutics Goes Private in $900M Biotech M&A Deal Revance Therapeutics, a pioneer in developing Botox-like products, has agreed to a $900 million acquisition that will take the company...

AbbVie's Transformative Acquisition of Cerevel Therapeutics AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is set to reshape the neuroscience landscape, unlocking innovative therapies and...

Rite Aid's Elixir Buyer Must Pay Additional $50M in Ch. 11 Sale In a pivotal move for its bankruptcy restructuring, embattled pharmacy chain Rite Aid has secured an additional $50 million from...

Pieris Pharma Stock Surges on Palvella Therapeutics Merger Deal Pieris Pharmaceuticals (PIRS) saw its stock soar by over 70% on July 24, 2024, following the announcement of an all-stock merger deal...

U.S. investment firm KKR, Singapore’s Temasek Holdings, and India’s Max Healthcare Institute are vying to buy TPG-backed chain of Care Hospitals in a deal worth over $1bn, Mint newspaper...